Drug Scheduling Actions

Final Rule: Placement of Eluxadoline Into Schedule IV; Correction (December 17, 2015)

Final Rule: Placement of Eluxadoline Into Schedule IV; Correction (November 16, 2015)

Proposed Rule: Placement of Three Synthetic Phenethylamines Into Schedule I (November 13, 2015)

Final Order: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I (November 13, 2015)

Final Rule: Placement of Eluxadoline Into Schedule IV (November 12, 2015)

Notice of Intent: Temporary Placement of the Synthetic Cannabinoid MAB-CHMINACA Into Schedule I (September 16, 2015)

Final Rule: Removal of [¹²³I]Ioflupane From Schedule II of the Controlled Substances Act (September 11, 2015)

Proposed Rule: Placement of Eluxadoline Into Schedule IV (August 11, 2015)

Final Order: Temporary Placement of Acetyl Fentanyl Into Schedule I (July 17, 2015)

Proposed Rule: Removal of [¹²³I]Ioflupane From Schedule II of the Controlled Substances Act (June 3, 2015)

Notice of Intent: Temporary Placement of Acetyl Fentanyl into Schedule I (May 21, 2015)

Final Order: Extension of Temporary Placement of UR-144, XLR11, and AKB48 in Schedule I of the Controlled Substances Act (May 15, 2015)

Proposed Rule: Placement of UR-144, XLR11, and AKB48 Into Schedule I (May 14, 2015)

Final Rule: Substances Temporarily Controlled Under Schedule I of the Controlled Substances Act (March 20, 2015)

Final Order: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I (January 30, 2015)

Final Rule: Removal of Naloxegol From Control (January 23, 2015)

Excluded Nonnarcotic Products

Interim Final Rule: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler (October 27, 2015)

Interim Final Rule: Table of Excluded Nonnarcotic Products: Vicks^® VapoInhaler^® (October 27, 2015)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).